{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:10:32Z","timestamp":1764493832318,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RBAP11884M_004"],"award-info":[{"award-number":["RBAP11884M_004"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003852","name":"Regione Campania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.intimp.2014.06.019","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:16:44Z","timestamp":1403569004000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells"],"prefix":"10.1016","volume":"22","author":[{"given":"Antonietta","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Misso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazario","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Donnarumma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Galdiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.06.019_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mib.2009.11.002","article-title":"Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment","volume":"13","author":"Saka","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0010","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2958.1993.tb01655.x","article-title":"The obligate intracellular bacterium Chlamydia trachomatis is auxotrophic for three of the four ribonucleoside triphosphates","volume":"8","author":"Tipples","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1574-6968.2002.tb11372.x","article-title":"Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line","volume":"215","author":"Carratelli","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.intimp.2014.06.019_bb0020","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.4049\/jimmunol.164.9.4812","article-title":"Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae","volume":"164","author":"Rottenberg","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/44.2.145","article-title":"Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma","volume":"44","author":"Cook","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.intimp.2014.06.019_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1479-5876-4-14","article-title":"Bacteria and cancer: cause, coincidence or cure? A review","volume":"4","author":"Mager","year":"2006","journal-title":"J Transl Med"},{"key":"10.1016\/j.intimp.2014.06.019_bb0035","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.90.9.3998","article-title":"Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro","volume":"90","author":"Beatty","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.intimp.2014.06.019_bb0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1468-3083.2001.00342.x","article-title":"Electron microscopic evidence of persistent chlamydial infection following treatment","volume":"15","author":"Bragina","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0045","doi-asserted-by":"crossref","first-page":"15971","DOI":"10.1073\/pnas.2535394100","article-title":"Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation","volume":"100","author":"Belland","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.intimp.2014.06.019_bb0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000314998","article-title":"Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India","volume":"56","author":"Bhengraj","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.intimp.2014.06.019_bb0055","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1099\/jmm.0.46348-0","article-title":"Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease","volume":"55","author":"Ikejima","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cyto.2011.06.027","article-title":"Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae","volume":"56","author":"Rizzo","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2014.06.019_bb0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1385\/IR:30:3:291","article-title":"Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression","volume":"30","author":"Marriott","year":"2004","journal-title":"Immunol Res"},{"key":"10.1016\/j.intimp.2014.06.019_bb0070","first-page":"273573","article-title":"Chlamydophila pneumoniae infection and its role in neurological disorders","author":"Contini","year":"2010","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.intimp.2014.06.019_bb0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cyto.2012.06.004","article-title":"Effect of resveratrol and modulation of cytokine production on human periodontal ligament cells","volume":"60","author":"Rizzo","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2014.06.019_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-160X-7-4","article-title":"The influence of bisphosphonates on human osteoblast migration and integrin aVb3\/tenascin C gene expression in vitro","volume":"7","author":"Koch","year":"2011","journal-title":"Head Face Med"},{"key":"10.1016\/j.intimp.2014.06.019_bb0085","doi-asserted-by":"crossref","first-page":"e19389","DOI":"10.1371\/journal.pone.0019389","article-title":"Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model","volume":"6","author":"Hung","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2014.06.019_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1677\/erc.1.01094","article-title":"Emerging anti-cancer molecular mechanisms of aminobisphosphonates","volume":"13","author":"Caraglia","year":"2006","journal-title":"Endocrinol Relat Cancer"},{"key":"10.1016\/j.intimp.2014.06.019_bb0095","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2174\/092986707781389600","article-title":"Zoledronic acid \u2014 a multiplicity of anti-cancer action","volume":"14","author":"Yuasa","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.intimp.2014.06.019_bb0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ctrv.2008.02.004","article-title":"Exploring the anti-tumour activity of bisphosphonates in early breast cancer","volume":"34","author":"Winter","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.intimp.2014.06.019_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0167-5699(93)90062-P","article-title":"The skin immune system: progress in cutaneous biology","volume":"14","author":"Bos","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.intimp.2014.06.019_bb0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/EC.00041-08","article-title":"Stress, drugs, and evolution: the role of cellular signalling in fungal drug resistance","volume":"7","author":"Cowen","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.intimp.2014.06.019_bb0115","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/jcm.30.8.1968-1971.1992","article-title":"Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae","volume":"30","author":"Roblin","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0120","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1128\/IAI.67.6.2909-2915.1999","article-title":"Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s)","volume":"67","author":"Coombes","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2014.06.019_bb0125","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bcp.2010.06.051","article-title":"Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae","volume":"80","author":"Salin","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.RES.0000095720.46043.F2","article-title":"Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous Heat Shock Protein 60","volume":"93","author":"Hirono","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.intimp.2014.06.019_bb0135","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.3748\/wjg.v11.i38.5973","article-title":"Damaging effects of gliadin on three-dimensional cell culture model","volume":"11","author":"Dolfini","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0140","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bcp.2005.12.006","article-title":"Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures","volume":"71","author":"Alvesalo","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10753-009-9111-9","article-title":"Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood","volume":"32","author":"Cazalis","year":"2009","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2014.06.019_bb0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/157489206778776989","article-title":"Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?","volume":"1","author":"Santini","year":"2006","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.intimp.2014.06.019_bb0155","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4161\/cbt.22274","article-title":"Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid","volume":"13","author":"Misso","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.intimp.2014.06.019_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00784-009-0312-2","article-title":"Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment","volume":"14","author":"Simon","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.intimp.2014.06.019_bb0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","article-title":"Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells","volume":"14","author":"Walter","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.intimp.2014.06.019_bb0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jcp.20960","article-title":"R115777 (Zarnestra)\/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk\/Akt inactivation and reduced Bcl-2 and bad phosphorylation","volume":"211","author":"Caraglia","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0175","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jcms.2011.10.024","article-title":"The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells","volume":"40","author":"A\u00e7il","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.intimp.2014.06.019_bb0180","first-page":"637976","article-title":"Bisphosphonates and cancer: what opportunities from nanotechnology?","author":"De Rosa","year":"2013","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.intimp.2014.06.019_bb0185","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/pbc.22681","article-title":"The use of zoledronic acid in pediatric cancer patients","volume":"56","author":"August","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.intimp.2014.06.019_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2169\/internalmedicine.51.6228","article-title":"The role of Chlamydia and Chlamydophila infections in reactive arthritis","volume":"51","author":"Rizzo","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.intimp.2014.06.019_bb0195","first-page":"1874","article-title":"Chlamydial nucleic acids in synovium in osteoarthritis: what are the implications?","volume":"28","author":"Olmez","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.intimp.2014.06.019_bb0200","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1128\/IAI.01259-08","article-title":"Proinflammatory response of human osteoblastic cell lines and osteoblast\u2013monocyte interaction upon infection with Brucella spp","volume":"77","author":"Delpino","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2014.06.019_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.intimp.2014.06.019_bb0210","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.micinf.2011.02.001","article-title":"Recent advances in Chlamydia subversion of host cytoskeletal and membrane trafficking pathways","volume":"13","author":"Scidmore","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.intimp.2014.06.019_bb0215","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","article-title":"An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates","volume":"61","author":"Thi\u00e9baud","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.intimp.2014.06.019_bb0220","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1128\/IAI.67.8.4231-4236.1999","article-title":"Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide","volume":"67","author":"Chiang","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2014.06.019_bb0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/154411130401500606","article-title":"Oral health, atherosclerosis, and cardiovascular disease","volume":"15","author":"Meurman","year":"2004","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.intimp.2014.06.019_bb0230","doi-asserted-by":"crossref","first-page":"e67906","DOI":"10.1371\/journal.pone.0067906","article-title":"Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages","volume":"8","author":"Muratsu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2014.06.019_bb0235","doi-asserted-by":"crossref","first-page":"e9887","DOI":"10.1371\/journal.pone.0009887","article-title":"Actin re-organization induced by Chlamydia trachomatis serovar D-evidence for a critical role of the effector protein CT166 targeting Rac","volume":"5","author":"Thalmann","year":"2010","journal-title":"PLoS ONE"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:06:55Z","timestamp":1761584815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1567576914002331"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.06.019","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}